0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Gene Therapy Market Research Report 2022
Published Date: July 2022
|
Report Code: QYRE-Othe-463
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cancer Gene Therapy Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Cancer Gene Therapy Market Research Report 2022

Code: QYRE-Othe-463
Report
July 2022
89 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global Cancer Gene Therapy Market
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.

The global Cancer Gene Therapy market size is projected to reach US$ 1657.7 million by 2028, from US$ 522 million in 2021, at a CAGR of 17.8% during 2022-2028.

Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Gene Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Gene Therapy market.
Global Cancer Gene Therapy Scope and Market Size
Cancer Gene Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy

Segment by Application

Hospitals
Diagnostics Centers
Research Institutes

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oncolytic Virotherapy
1.2.3 Gene Transfer
1.2.4 Gene-Induced Immunotherapy
1.3 Market by Application
1.3.1 Global Cancer Gene Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Therapy Market Perspective (2017-2028)
2.2 Cancer Gene Therapy Growth Trends by Region
2.2.1 Cancer Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Gene Therapy Historic Market Size by Region (2017-2022)
2.2.3 Cancer Gene Therapy Forecasted Market Size by Region (2023-2028)
2.3 Cancer Gene Therapy Market Dynamics
2.3.1 Cancer Gene Therapy Industry Trends
2.3.2 Cancer Gene Therapy Market Drivers
2.3.3 Cancer Gene Therapy Market Challenges
2.3.4 Cancer Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Gene Therapy Players by Revenue
3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2017-2022)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
3.4 Global Cancer Gene Therapy Market Concentration Ratio
3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2021
3.5 Cancer Gene Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Gene Therapy Product Solution and Service
3.7 Date of Enter into Cancer Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Gene Therapy Breakdown Data by Type
4.1 Global Cancer Gene Therapy Historic Market Size by Type (2017-2022)
4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2023-2028)
5 Cancer Gene Therapy Breakdown Data by Application
5.1 Global Cancer Gene Therapy Historic Market Size by Application (2017-2022)
5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Gene Therapy Market Size (2017-2028)
6.2 North America Cancer Gene Therapy Market Size by Country (2017-2022)
6.3 North America Cancer Gene Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Gene Therapy Market Size (2017-2028)
7.2 Europe Cancer Gene Therapy Market Size by Country (2017-2022)
7.3 Europe Cancer Gene Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Gene Therapy Market Size (2017-2028)
8.2 Asia-Pacific Cancer Gene Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Gene Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Gene Therapy Market Size (2017-2028)
9.2 Latin America Cancer Gene Therapy Market Size by Country (2017-2022)
9.3 Latin America Cancer Gene Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Gene Therapy Market Size (2017-2028)
10.2 Middle East & Africa Cancer Gene Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Detail
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Cancer Gene Therapy Introduction
11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2017-2022)
11.1.5 Adaptimmune Recent Development
11.2 Bluebird bio
11.2.1 Bluebird bio Company Detail
11.2.2 Bluebird bio Business Overview
11.2.3 Bluebird bio Cancer Gene Therapy Introduction
11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2017-2022)
11.2.5 Bluebird bio Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Gene Therapy Introduction
11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2017-2022)
11.3.5 Celgene Recent Development
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Detail
11.4.2 Shanghai Sunway Biotech Business Overview
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2017-2022)
11.4.5 Shanghai Sunway Biotech Recent Development
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Detail
11.5.2 Shenzhen SiBiono GeneTech Business Overview
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2017-2022)
11.5.5 Shenzhen SiBiono GeneTech Recent Development
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Detail
11.6.2 SynerGene Therapeutics Business Overview
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2017-2022)
11.6.5 SynerGene Therapeutics Recent Development
11.7 Altor BioScience
11.7.1 Altor BioScience Company Detail
11.7.2 Altor BioScience Business Overview
11.7.3 Altor BioScience Cancer Gene Therapy Introduction
11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2017-2022)
11.7.5 Altor BioScience Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Cancer Gene Therapy Introduction
11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2017-2022)
11.8.5 Amgen Recent Development
11.9 Argenx
11.9.1 Argenx Company Detail
11.9.2 Argenx Business Overview
11.9.3 Argenx Cancer Gene Therapy Introduction
11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2017-2022)
11.9.5 Argenx Recent Development
11.10 BioCancell
11.10.1 BioCancell Company Detail
11.10.2 BioCancell Business Overview
11.10.3 BioCancell Cancer Gene Therapy Introduction
11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2017-2022)
11.10.5 BioCancell Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2017-2022)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Cancer Gene Therapy Introduction
11.12.4 Merck Revenue in Cancer Gene Therapy Business (2017-2022)
11.12.5 Merck Recent Development
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Detail
11.13.2 OncoGenex Pharmaceuticals Business Overview
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2017-2022)
11.13.5 OncoGenex Pharmaceuticals Recent Development
11.14 Transgene
11.14.1 Transgene Company Detail
11.14.2 Transgene Business Overview
11.14.3 Transgene Cancer Gene Therapy Introduction
11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2017-2022)
11.14.5 Transgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Oncolytic Virotherapy
    Table 3. Key Players of Gene Transfer
    Table 4. Key Players of Gene-Induced Immunotherapy
    Table 5. Global Cancer Gene Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Cancer Gene Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Cancer Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Cancer Gene Therapy Market Share by Region (2017-2022)
    Table 9. Global Cancer Gene Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Cancer Gene Therapy Market Share by Region (2023-2028)
    Table 11. Cancer Gene Therapy Market Trends
    Table 12. Cancer Gene Therapy Market Drivers
    Table 13. Cancer Gene Therapy Market Challenges
    Table 14. Cancer Gene Therapy Market Restraints
    Table 15. Global Cancer Gene Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Cancer Gene Therapy Market Share by Players (2017-2022)
    Table 17. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2021)
    Table 18. Ranking of Global Top Cancer Gene Therapy Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cancer Gene Therapy Product Solution and Service
    Table 22. Date of Enter into Cancer Gene Therapy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cancer Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2017-2022)
    Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2023-2028)
    Table 28. Global Cancer Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Cancer Gene Therapy Revenue Market Share by Application (2017-2022)
    Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Cancer Gene Therapy Revenue Market Share by Application (2023-2028)
    Table 32. North America Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Cancer Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Cancer Gene Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Adaptimmune Company Detail
    Table 43. Adaptimmune Business Overview
    Table 44. Adaptimmune Cancer Gene Therapy Product
    Table 45. Adaptimmune Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 46. Adaptimmune Recent Development
    Table 47. Bluebird bio Company Detail
    Table 48. Bluebird bio Business Overview
    Table 49. Bluebird bio Cancer Gene Therapy Product
    Table 50. Bluebird bio Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 51. Bluebird bio Recent Development
    Table 52. Celgene Company Detail
    Table 53. Celgene Business Overview
    Table 54. Celgene Cancer Gene Therapy Product
    Table 55. Celgene Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 56. Celgene Recent Development
    Table 57. Shanghai Sunway Biotech Company Detail
    Table 58. Shanghai Sunway Biotech Business Overview
    Table 59. Shanghai Sunway Biotech Cancer Gene Therapy Product
    Table 60. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 61. Shanghai Sunway Biotech Recent Development
    Table 62. Shenzhen SiBiono GeneTech Company Detail
    Table 63. Shenzhen SiBiono GeneTech Business Overview
    Table 64. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
    Table 65. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 66. Shenzhen SiBiono GeneTech Recent Development
    Table 67. SynerGene Therapeutics Company Detail
    Table 68. SynerGene Therapeutics Business Overview
    Table 69. SynerGene Therapeutics Cancer Gene Therapy Product
    Table 70. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 71. SynerGene Therapeutics Recent Development
    Table 72. Altor BioScience Company Detail
    Table 73. Altor BioScience Business Overview
    Table 74. Altor BioScience Cancer Gene Therapy Product
    Table 75. Altor BioScience Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 76. Altor BioScience Recent Development
    Table 77. Amgen Company Detail
    Table 78. Amgen Business Overview
    Table 79. Amgen Cancer Gene Therapy Product
    Table 80. Amgen Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 81. Amgen Recent Development
    Table 82. Argenx Company Detail
    Table 83. Argenx Business Overview
    Table 84. Argenx Cancer Gene Therapy Product
    Table 85. Argenx Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 86. Argenx Recent Development
    Table 87. BioCancell Company Detail
    Table 88. BioCancell Business Overview
    Table 89. BioCancell Cancer Gene Therapy Product
    Table 90. BioCancell Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 91. BioCancell Recent Development
    Table 92. GlaxoSmithKline Company Detail
    Table 93. GlaxoSmithKline Business Overview
    Table 94. GlaxoSmithKline Cancer Gene TherapyProduct
    Table 95. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 96. GlaxoSmithKline Recent Development
    Table 97. Merck Company Detail
    Table 98. Merck Business Overview
    Table 99. Merck Cancer Gene TherapyProduct
    Table 100. Merck Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 101. Merck Recent Development
    Table 102. OncoGenex Pharmaceuticals Company Detail
    Table 103. OncoGenex Pharmaceuticals Business Overview
    Table 104. OncoGenex Pharmaceuticals Cancer Gene TherapyProduct
    Table 105. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 106. OncoGenex Pharmaceuticals Recent Development
    Table 107. Transgene Company Detail
    Table 108. Transgene Business Overview
    Table 109. Transgene Cancer Gene TherapyProduct
    Table 110. Transgene Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
    Table 111. Transgene Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Gene Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Oncolytic Virotherapy Features
    Figure 3. Gene Transfer Features
    Figure 4. Gene-Induced Immunotherapy Features
    Figure 5. Global Cancer Gene Therapy Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Diagnostics Centers Case Studies
    Figure 8. Research Institutes Case Studies
    Figure 9. Cancer Gene Therapy Report Years Considered
    Figure 10. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Cancer Gene Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cancer Gene Therapy Market Share by Region: 2021 VS 2028
    Figure 13. Global Cancer Gene Therapy Market Share by Players in 2021
    Figure 14. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2021
    Figure 16. North America Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Cancer Gene Therapy Market Share by Country (2017-2028)
    Figure 18. United States Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Cancer Gene Therapy Market Share by Country (2017-2028)
    Figure 22. Germany Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Cancer Gene Therapy Market Share by Region (2017-2028)
    Figure 30. China Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Cancer Gene Therapy Market Share by Country (2017-2028)
    Figure 38. Mexico Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Cancer Gene Therapy Market Share by Country (2017-2028)
    Figure 42. Turkey Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 45. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 46. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 47. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 48. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 49. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 50. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 51. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 52. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 53. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 54. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 55. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 56. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 57. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS